Cigna Corporation
NYSE:CIMedical - Healthcare Plans
Healthcare
$270.90 -1.56%
-$4.44 today
- Market cap
- $71.38B
- Beta
- 0.30
- P/E (TTM)
- 11.7
- EPS (TTM)
- $23.95
- Dividend yield
- 2.19%
52W Low $239.51High $338.89
Volume 2.62M
Average 1.61M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$9.60B
FY 2025 · Annual
-7.4% YoYInvesting Cash Flow
-$4.41B
FY 2025 · Annual
Financing Cash Flow
-$6.42B
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 5.42B | 6.78B | 5.37B | 3.78B | 6.29B |
| Depreciation & Amortization | 2.92B | 2.94B | 3.04B | 2.78B | 2.78B |
| Deferred Income Tax | (216M) | (472M) | (1.66B) | (95M) | 326M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (879M) | 259M | 3.03B | 418M | (261M) |
| Accounts Receivables | (3.5B) | (2.24B) | (1.66B) | (7.37B) | (4.63B) |
| Inventory | (557M) | (1.06B) | (868M) | (1.03B) | (646M) |
| Accounts Payables | 2.04B | 1.73B | 3.48B | 1.14B | 2.8B |
| Other Working Capital | 1.14B | 1.82B | 2.08B | 7.68B | 2.22B |
| Other Non-Cash Items | (57M) | (850M) | 2.04B | 3.49B | 473M |
| Operating Cash Flow | 7.19B | 8.66B | 11.81B | 10.36B | 9.6B |
| Capital Expenditures | (1.15B) | (1.3B) | (1.57B) | (1.41B) | (1.21B) |
| Acquisitions (Net) | (1.89B) | 4.84B | (434M) | 390M | 2.39B |
| Purchases of Investments | (6.11B) | (4.32B) | (5.54B) | (2.7B) | (7.2B) |
| Sales of Investments | 5.59B | 4.11B | 2.64B | 2.45B | 2.65B |
| Other Investing Activities | (50M) | (233M) | (264M) | (838M) | (1.03B) |
| Investing Cash Flow | (3.61B) | 3.1B | (5.17B) | (2.1B) | (4.41B) |
| Debt Repayment | 657M | (2.56B) | (278M) | 1.06B | (666M) |
| Common Stock Issued | 326M | 389M | 187M | 305M | 203M |
| Common Stock Repurchased | (7.74B) | (7.61B) | (2.28B) | (7.03B) | (3.62B) |
| Dividends Paid | (1.34B) | (1.38B) | (1.45B) | (1.57B) | (1.61B) |
| Other Financing Activities | (112M) | (79M) | (469M) | (411M) | (726M) |
| Financing Cash Flow | (8.21B) | (11.24B) | (4.29B) | (7.65B) | (6.42B) |
| Effect of Forex Changes | (65M) | (86M) | 16M | (20M) | 1.35B |
| Net Change in Cash | (4.7B) | 428M | 2.36B | 594M | 126M |
| Free Cash Flow | 6.04B | 7.36B | 10.24B | 8.96B | 8.39B |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$6.3B
+ D&A$2.8B
+ Stock-Based Comp$0
+ Deferred Tax$326.0M
- Working Capital-$261.0M
+ Other Non-Cash$473.0M
= Operating Cash Flow$9.6B
- Capex-$1.2B
= Free Cash Flow$8.4B
Analysis
FY2025 free cash flow is $8.4B. FCF conversion is 133.4% of net income. Operating cash flow was $9.6B, with capex of -$1.2B. The largest bridge item is D&A at $2.8B.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Oct 9, 2026 | |
| 8-K | Current report | Sep 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 8, 2026 |
Does CI generate free cash flow?
Cigna Corporation (CI) generated $8.39B of free cash flow in fiscal 2025.
How much operating cash flow does CI produce?
Operating cash flow was $9.60B, before capital expenditures of $1.21B.
Continue the stock analysis
Jump to another research area for this company.